Roche Holding AG (OTCMKTS:RHHBY) Shares Sold by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS cut its holdings in shares of Roche Holding AG (OTCMKTS:RHHBYFree Report) by 8.2% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 233,756 shares of the company’s stock after selling 20,891 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Roche were worth $8,488,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in RHHBY. Thomas White International Ltd. raised its holdings in Roche by 5.0% during the first quarter. Thomas White International Ltd. now owns 38,072 shares of the company’s stock worth $1,895,000 after purchasing an additional 1,810 shares in the last quarter. SVB Wealth LLC raised its holdings in Roche by 101.3% during the first quarter. SVB Wealth LLC now owns 34,152 shares of the company’s stock worth $1,687,000 after purchasing an additional 17,188 shares in the last quarter. Captrust Financial Advisors raised its holdings in Roche by 21.5% during the first quarter. Captrust Financial Advisors now owns 40,357 shares of the company’s stock worth $1,998,000 after purchasing an additional 7,150 shares in the last quarter. Principal Street Partners LLC bought a new stake in Roche during the fourth quarter worth approximately $341,000. Finally, Russell Investments Group Ltd. bought a new stake in Roche during the first quarter worth approximately $103,000.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Morgan Stanley cut Roche from an “equal weight” rating to an “underweight” rating in a report on Tuesday, January 16th. Argus reaffirmed a “hold” rating on shares of Roche in a report on Monday, March 4th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $40.00.

Get Our Latest Stock Report on RHHBY

Roche Stock Up 1.2 %

Shares of OTCMKTS RHHBY traded up $0.36 during trading on Friday, hitting $30.41. The company had a trading volume of 18,593,670 shares, compared to its average volume of 3,155,297. The business’s 50-day moving average is $32.07 and its 200 day moving average is $33.73. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.35 and a quick ratio of 1.04. Roche Holding AG has a 52 week low of $29.95 and a 52 week high of $40.48.

Roche Profile

(Free Report)

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

Further Reading

Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBYFree Report).

Institutional Ownership by Quarter for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.